Profile picture

Professor Maryam Kavousi

Erasmus University Medical Centre, Rotterdam (Netherlands (The))
Membership: FESC Member EAPC Member
Follow
Biography
Prof. Dr. Maryam Kavousi MD PhD is Professor of Population Cardiovascular Health and Principal Investigator of Cardiometabolic Epidemiology. Her research is focused on primary prevention of cardiovascular disease, emphasizing sex- and gender-related aspects. Her studies generate new knowledge about population cardiovascular health with the goal of applying this knowledge to discover new biology, inform precision cardiovascular prevention strategies, and reduce the burden of cardiovascular disease. Prof. Dr. Kavousi is a member of the Young Academy of the Royal Netherlands Academy of Arts and Sciences. She has received multiple (prestigious) Dutch and European research grants and awards. Prof. Dr. Kavousi has (co)authored over 250 peer-reviewed scientific articles (H-index: 78) published in leading scientific journals. (https://www.ncbi.nlm.nih.gov/pubmed/?term=kavousi+M)
Logo ESC

Contributor content

Closing session
Session
Closing session
25 April 2026
Genetics and imaging for risk prediction: when does it really help?
Session
Genetics and imaging for risk prediction: when does it really help?
25 April 2026
Pulsed field ablation circular catheters
Session
Pulsed field ablation circular catheters
12 April 2026
Risk factors (4)
Session
Risk factors (4)
30 August 2025
The environment as a major cardiovascular risk factor
Session
The environment as a major cardiovascular risk factor
3 April 2025
Late breaking science on estimating cardiovascular risk
Session
Late breaking science on estimating cardiovascular risk
3 April 2025
Estimating cardiovascular risk: does one score fit all?
Session
Estimating cardiovascular risk: does one score fit all?
3 April 2025
Novel biomarkers for cardiovascular risk prediction
Session
Novel biomarkers for cardiovascular risk prediction
1 September 2024
Risk score for risk prediction in cardiovascular disease
Session
Risk score for risk prediction in cardiovascular disease
31 August 2024
2nd Session
Session
2nd Session
4 May 2024

ESC 365 is supported by